NIAID Banner Logo Image

HIV Citations List: October, 2018

Literature Citations

1. Design, Synthesis and Identification of Novel Substituted Isothiochromene Analogs as Potential Antiviral and Cytotoxic Agents. Abu-Hashem, A.A., M.A. Gouda, and F.A. Badria. Medicinal Chemistry Research, 2018. 27(10): p. 2297-2311. ISI[000444949700006].
[WOS]. HIV_10_2018.

2. Efficacy of Vaginally Administered Gel Containing Emtricitabine and Tenofovir against Repeated Rectal Simian Human Immunodeficiency Virus Exposures in Macaques. Dobard, C.W., N. Makarova, R. West-Deadwyler, A. Taylor, C. Dinh, A. Martin, J. Lipscomb, J. Mitchell, G. Khalil, G. Garcia-Lerma, and W. Heneine. Journal of Infectious Diseases, 2018. 218(8): p. 1284-1290. PMID[29788316]. PMCID[PMC6129108].
[PubMed]. HIV_10_2018.

3. Design, Synthesis, Docking Studies and Biological Screening of 2-Thiazolyl substituted-2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as Potent HIV-1 Reverse Transcriptase Inhibitors.Gawali, R., J. Trivedi, S. Bhansali, R. Bhosale, D. Sarkar, and D. Mitra. European Journal of Medicinal Chemistry, 2018. 157: p. 310-319. PMID[30099253].
[PubMed]. HIV_10_2018.

4. Synthesis and Evaluation of Aryl Quinolines as HIV-1 Integrase Multimerization Inhibitors. Jentsch, N.G., A.P. Hart, J.D. Hume, J. Sun, K.A. McNeely, C.Y. Lama, J.A. Pigza, M.G. Donahue, and J.J. Kessl. ACS Medicinal Chemistry Letters, 2018. 9(10): p. 1007-1012. PMID[30344908]. PMCID[PMC6187413].
[PubMed]. HIV_10_2018.

5. Design and Synthesis of a Novel Series of Non-nucleoside HIV-1 Inhibitors Bearing Pyrimidine and N-substituted Aromatic Piperazine. Jin, K.J., Y.L. Sang, E. De Clercq, C. Pannecouque, and G. Meng. Bioorganic & Medicinal Chemistry Letters, 2018. 28(22): p. 3491-3495. PMID[30318436].
[PubMed]. HIV_10_2018.

6. Synthesis and in Vitro Anti-tumor, Anti-mycobacterial and anti-HIV Activities of Diethylene-glycol-tethered bis-Isatin Derivatives. Li, W., S.J. Zhao, F. Gao, Z.S. Lv, J.Y. Tu, and Z. Xu. ChemistrySelect, 2018. 3(36): p. 10250-10254. ISI[000445850200020].
[WOS]. HIV_10_2018.

7. PR-957, a Selective Immunoproteasome Inhibitor, Reactivates Latent HIV-1 through P-TEFb Activation Mediated by HSF-1. Lin, J., X. Zhang, W. Lu, X. Xu, X. Pan, T. Liang, S. Duan, Y. Chen, L. Li, and S. Liu. Biochemical Pharmacology, 2018. 156: p. 511-523. PMID[30170098].
[PubMed]. HIV_10_2018.

8. Herbal Gel Formulation Developed for Anti-human Immunodeficiency Virus (HIV)-1 Activity Also Inhibits in Vitro HSV-2 Infection. Mishra, N.N., A. Kesharwani, A. Agarwal, S.K. Polachira, R. Nair, and S.K. Gupta. Viruses, 2018. 10(11): E580. PMID[30352961].
[PubMed]. HIV_10_2018.

9. An Aromatic Farnesyltransferase Functions in Biosynthesis of the anti-HIV Meroterpenoid daurichromenic acid.Saeki, H., R. Hara, H. Takahashi, M. Iijima, R. Munakata, H. Kenmoku, K. Fuku, A. Sekihara, Y. Yasuno, T. Shinada, D. Ueda, T. Nishi, T. Sato, Y. Asakawa, F. Kurosaki, K. Yazaki, and F. Taura. Plant Physiology, 2018. 178(2): p. 535-551. PMID[30097469]. PMCID[PMC6181053].
[PubMed]. HIV_10_2018.

10. Synthesis and Biological Evaluation of Novel Indole-derived Thioureas. Sanna, G., S. Madeddu, G. Giliberti, S. Piras, M. Struga, M. Wrzosek, G. Kubiak-Tomaszewska, A.E. Koziol, O. Savchenko, T. Lis, J. Stefanska, P. Tomaszewski, M. Skrzycki, and D. Szulczyk. Molecules, 2018. 23(10): E2554. PMID[30301264].
[PubMed]. HIV_10_2018.

11. Synthesis and Biological Evaluation of 8-Hydroxyquinoline-hydrazones for anti-HIV-1and Anticancer Potential. Shah, P., L.F. Abadi, S. Gaikwad, D. Chaudhari, V. Kushwah, S. Jain, K.K. Bhutani, S. Kulkarni, and I.P. Singh. ChemistrySelect, 2018. 3(38): p. 10727-10731. ISI[000447546900031].
[WOS]. HIV_10_2018.

12. Synthetic Ingenols Maximize Protein Kinase C-Induced HIV-1 Latency Reversal. Spivak, A.M., R.A. Nell, M. Petersen, L. Martins, P. Sebahar, R.E. Looper, and V. Planelles. Antimicrobial Agents and Chemotherapy, 2018. 62(11): e01361-18. PMID[30104276].
[PubMed]. HIV_10_2018.

13. A Novel PKC Activator, 10-Methyl-aplog-1 Efficiently Reactivate Latent HIV-1 in Combination with a BET Inhibitor JQ1. Washizaki, A., M. Murata, Y.P. Tang, Y. Seki, K. Irie, and H. Akari. Journal of Medical Primatology, 2018. 47(5): p. 350-350. ISI[000445618600116].
[WOS]. HIV_10_2018.

14. Discovery of Phenylalanine Derivatives as Potent HIV-1 Capsid Inhibitors from Click Chemistry-based Compound Library. Wu, G., W.A. Zalloum, M.E. Meuser, L. Jing, D. Kang, C.H. Chen, Y. Tian, F. Zhang, S. Cocklin, K.H. Lee, X. Liu, and P. Zhan. European Journal of Medicinal Chemistry, 2018. 158: p. 478-492. PMID[30243152].
[PubMed]. HIV_10_2018.

15. HIV-1 Inhibitory Properties of eCD4-Igmim2 Determined Using an Env-mediated Membrane Fusion Assay. Yang, E., M.R. Gardner, A.S. Zhou, M. Farzan, A.M. Arvin, and S.L. Oliver. Plos One, 2018. 13(10): e0206365. PMID[30359435].
[PubMed]. HIV_10_2018.

Patent Citations

16. Anti-leukemic, anti-HIV, and Sialidase Activities of Royal-jelly Proteins. El-Fiky, S.I.S., M.M.A.-S. Ali, and N.H.H.M. Abd Al-Galil. Patent. 2018. 2018-EG12 2018188714: 19pp.
[Patent]. HIV_10_2018.

Database last updated: September 2018